Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q2 2026 Earnings

13MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-0.46

-0.36

-0.25

-0.15

Details

Expected EPS

-0.20034

Actual EPS

N/A

Surprise EPS

0.2

Surprise Percent

+100%

Description

Relmada Therapeutics (RLMD) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.